Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis - Test2 - elhamkhani - TriplyDB

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

http://www.wikidata.org/entity/Q28213371

about

sameAs

Microarray analysis of gene expression in lupus Interpreting interest in interferon-alpha Endothelial cell activation and neovascularization are prominent in dermatomyositis Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity Coexpression analysis of human genes across many microarray data sets Protein arrays for studying blood cells and their secreted products.Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.Disease-associated pathophysiologic structures in pediatric rheumatic diseases show characteristics of scale-free networks seen in physiologic systems: implications for pathogenesis and treatment.Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.A genomic approach to human autoimmune diseases.Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiency.Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis.Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.Dendritic cell subsets in health and disease.Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.A randomized, pilot trial of etanercept in dermatomyositis.The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage Recent advances in the immunogenetics of idiopathic inflammatory myopathy.Microarray analysis of interferon-regulated genes in SLE.Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.The heterogeneity of juvenile myositis Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells Type I interferon pathway in adult and juvenile dermatomyositis.Involvement of dendritic cells in autoimmune diseases in children.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.The type I interferon system in systemic lupus erythematosus.Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.

P2860

Q24795089-4503BD32-59DB-4828-8599-578E4929C86F Q24797820-4EC20419-4B83-4B50-8FC6-29964EACDA34 Q25256876-16D4C768-DF61-4F09-93ED-0F400B9AEEE4 Q28246851-B87EDE18-5958-47F4-AF57-7B6E2F05BBE9 Q28246912-FAF72EC8-605A-40BB-95B7-A8543F338151 Q28287170-A80BDF42-D94B-4100-B849-DE5239071089 Q28303311-3CA03127-7FC6-4942-8FAB-CD6EED07754D Q30936126-000660AF-9B92-40EF-AA8E-CB201640CF45 Q33213208-A1EF6245-9796-4656-8FB2-11E9894689DA Q33283212-C9942442-566A-4D45-A90C-55C6F79CE770 Q33356785-BC1E4080-776F-4903-8983-C0C4250341DB Q33411566-B65BE235-1BA8-4132-AAF8-92207035874E Q33694649-56E65330-1E19-4B94-9254-E1DF41B4A4CC Q33762839-DCB929AF-0D32-446E-AEEE-879EEE6488A9 Q33952797-CE99543C-CFE2-4E9C-940B-F466216BB2B9 Q33998204-8BA819D3-55CB-4F40-B5E8-0BD559EC036E Q34123569-C2A7D647-34E3-45F9-AA62-0180DDA07196 Q34185599-823527B4-377A-4E27-87C3-3B40E76BE5EE Q34214035-C55E177B-4477-44B8-9F97-C93BD6606550 Q34332718-7BBB146F-94E5-42AC-9289-D2181428FFE7 Q34582889-A1FA7977-4530-4FF5-A50E-8BAF7681FB65 Q34764290-439C812F-6A55-4832-BD5E-B76A1264010C Q35009335-44F93732-E420-4450-A9A1-0E5DD41CF0BF Q35093048-19270FD6-BBA1-4746-A184-C35CE0D1C09B Q35112489-59A745CF-FC08-4ED5-9F1F-98803EFB0F5B Q35184886-8FF65BDB-A296-474B-AC3F-1520B6C2EFF7 Q35206687-F3D242B7-565A-4E5E-8966-7380371DD98F Q35464924-4619345F-04D4-4DB8-B58D-0214E7C72801 Q35557800-8572CA1A-3B41-4281-AF93-B3037F98332B Q35675519-069A39AC-AD8E-4541-AF3A-E8CF1D7CFFDF Q35681780-D2EC474C-DD04-4758-B898-61EEE24FB1C3 Q35748264-09B61059-C661-40D1-B874-BC0A5C831A04 Q35824472-E1138ED2-910D-455A-A5B8-EA135FB7F335 Q35854122-1B7D1210-E69D-4ED0-B3ED-650F3B9549B0 Q35907790-268B1432-7E5B-488E-B8CB-5EE27711C50A Q35946403-70185B4E-AD2D-48C4-8C55-CDA733FB8F6C Q36312962-B7821B60-4A6C-4F89-B6E6-F4AA86A03B18 Q36338717-4C31C616-1816-454C-A476-5F1CF60C3383 Q36382207-CE7EC447-E8AC-4D2B-B597-FC000912E21A Q36417352-C16719C0-24CF-490E-84C7-54444FBC14C0

P2860

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

http://www.wikidata.org/entity/Q28213371

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Gene expression profiling in D ...... a novel model of pathogenesis

@ast

Gene expression profiling in D ...... a novel model of pathogenesis

@en

Gene expression profiling in D ...... a novel model of pathogenesis

@nl

type

label

Gene expression profiling in D ...... a novel model of pathogenesis

@ast

Gene expression profiling in D ...... a novel model of pathogenesis

@en

Gene expression profiling in D ...... a novel model of pathogenesis

@nl

prefLabel

Gene expression profiling in D ...... a novel model of pathogenesis

@ast

Gene expression profiling in D ...... a novel model of pathogenesis

@en

Gene expression profiling in D ...... a novel model of pathogenesis

@nl

P1433

Q28213371-18B1A286-5989-4B4E-A444-AC858C0CE903

P1476

Q28213371-E6C602C1-7D35-425F-96D4-B2971C725D35

P2093

Q28213371-059C2B0E-3B8C-4D84-9AE9-FF33B8B4607D

Q28213371-0A26B2C6-61A8-47CE-991B-ABAC61C33E75

Q28213371-179C633B-5C97-4196-9143-A2E95E19433C

Q28213371-3B5552B7-91E3-4858-A1AB-7882D041ADF4

Q28213371-63978C0A-DC40-4B93-B964-8CA5CCE34F56

Q28213371-7F6F84A6-61CF-4EC8-B1E2-467EC47ECA31

Q28213371-96913644-2692-4ADE-9423-1614030C70F3

Q28213371-99926ABA-5A05-4E62-A486-52FC5328A610

Q28213371-C371A994-BB40-4064-ACC2-6D8828789250

P304

Q28213371-0E0799D2-F427-4009-B640-772E761DAC60

P31

Q28213371-5F4AB8AE-96D7-4988-8715-8DD77B333786

P3181

Q28213371-9F797FEA-6DC4-4550-BFCB-D475ECA18C1E

P356

Q28213371-5B0A572D-9737-4165-88EF-1222EB4A2B81

P407

Q28213371-DA26D8B5-08C4-4F91-867A-FA50C439CBFB

P433

Q28213371-19734425-0780-4E8A-9121-385B1ED8D10F

P478

Q28213371-3B8A3AEB-19C0-403B-A818-07D40643C96E

P577

Q28213371-DD71EC90-53CA-49A5-8BE9-35F04209CE0B

P5875

Q28213371-DB8B6ACA-D1BF-443A-BC19-D30B2A57F358

P698

Q28213371-EC6DF9A5-3D16-4CF7-92E7-FD13C7C240D7

P921

Q28213371-589BD82E-3690-4669-964C-071F2638EC77

Q28213371-927D0C77-D270-496F-8EA1-55A6F39DC593

P3181

P356

JIMMUNOL.168.8.4154

P1433

Journal of Immunology

P1476

Gene expression profiling in D ...... a novel model of pathogenesis

@en

P2093

Ajit Kumar

http://www.w3.org/2001/XMLSchema#string

Dietrich Stephan

http://www.w3.org/2001/XMLSchema#string

Eric G Bremer

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

Irina Krasnoselska-Riz

http://www.w3.org/2001/XMLSchema#string

Jennica L Lutz

http://www.w3.org/2001/XMLSchema#string

Lauren M Pachman

http://www.w3.org/2001/XMLSchema#string

Tamara O Fedczyna

http://www.w3.org/2001/XMLSchema#string

Zivana Tezak

http://www.w3.org/2001/XMLSchema#string

P304

4154-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2052033

http://www.w3.org/2001/XMLSchema#string

P356

10.4049/JIMMUNOL.168.8.4154

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11427904

http://www.w3.org/2001/XMLSchema#string

P698

11937576

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis